National Stroke Foundation

Atracurium Besylate Injection

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved April 1997

Specific Treatments:

muscle relaxant

Therapeutic Areas

General Information

Preserved and unpreserved forms of Atracurium Besylate Injection, an intermediate duration muscle relaxant, have been approved for marketing. The drugs are the generic equivalents of Tracrium, an adjunct to general anesthesia during surgery or mechanical ventilation that is marketed by GlaxoWellcome.